[Osteoporosis and bone morphogenetic protein (BMP)].
Higuchi
Chikahisa
C
Medical Center for Translational Research, Osaka University Hospital.
Nakase
Takanobu
T
D000818:Animals; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000235:genetics / Q000502:physiology*; D016723:Bone Remodeling; D001842:Bone and Bones / Q000378:metabolism; D015195:Drug Design; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D010024:Osteoporosis / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D016212:Transforming Growth Factor beta / Q000235:genetics
C525718:BMP2 protein, human; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D016212:Transforming Growth Factor beta